相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Albumin from human serum does not contain asymmetric dimethylarginine (ADMA)
Dimitrios Tsikas et al.
CLINICAL BIOCHEMISTRY (2009)
Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection-Role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system
Jan T. Kielstein et al.
CRITICAL CARE MEDICINE (2009)
Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease
Jan T. Kielstein et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2008)
Asymmetrical dimethylarginine in renal disease: Limits of variation or variation limits?
Johannes Jacobi et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease
Yuriko Matsumoto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study)
Andreas Meinitzer et al.
CLINICAL CHEMISTRY (2007)
ADMA correlates with portal pressure in patients with compensated cirrhosis
F. Vizzutti et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis
Rajeshwar P. Mookerjee et al.
HEPATOLOGY (2007)
Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: Ramipril versus valsartan
Mahmut Ilker Yilmaz et al.
BLOOD PURIFICATION (2007)
Contribution of whole blood to the control of plasma asymmetrical dimethylarginine
Scott S. Billecke et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function - a meta-analysis
Jan T. Kielstein et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
ADMA increases arterial stiffness and decreases cerebral blood flow in humans
Jan T. Kielstein et al.
STROKE (2006)
ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease
K. Caglar et al.
KIDNEY INTERNATIONAL (2006)
Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass Spectrometry
J Martens-Lobenhoffer et al.
CLINICAL CHEMISTRY (2006)
Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond
RH Boger
ANNALS OF MEDICINE (2006)
Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease
M Tanaka et al.
CIRCULATION (2005)
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease -: Results from the AtheroGene study
R Schnabel et al.
CIRCULATION RESEARCH (2005)
Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension
JT Kielstein et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
The Prometheus (R) device for extracorporeal support of combined liver and renal failure
K Rifai et al.
BLOOD PURIFICATION (2005)
Detoxifying capacity and kinetics of Prometheus (R) - A new extracorporeal system for the treatment of liver failure
P Evenepoel et al.
BLOOD PURIFICATION (2005)
Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans
JT Kielstein et al.
CIRCULATION (2004)
Relationship of asymmetric dimethylarginine to haemodialysis hypotension
S Bergamini et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2004)
Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition
JT Kielstein et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2004)
Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis - Genetic and physiological evidence
H Dayoub et al.
CIRCULATION (2003)
Asymmetric dimethylarginine (ADMA):: a key regulator of nitric oxide synthase
RH Böger et al.
ATHEROSCLEROSIS SUPPLEMENTS (2003)
Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
V Achan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA)
RJ Nijveldt et al.
CLINICAL NUTRITION (2003)
Prometheus (R) - a new extracorporeal system for the treatment of liver failure
K Rifai et al.
JOURNAL OF HEPATOLOGY (2003)
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease:: a prospective study
C Zoccali et al.
LANCET (2001)
分享论文
